Press Release

View printer-friendly version Back

Lantheus Medical Imaging to Host Fourth Quarter 2012 Conference Call on April 2, 2013 at 4:00 p.m. Eastern Time

N. Billerica, Mass., March 28, 2013 – Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Tuesday, April 2, 2013, to discuss its financial and operating results for the fourth quarter and full year of 2012.

To access the live conference call via telephone, please dial 1-800-299-9086 (U.S. callers) or 1-617-786-2903 (international callers) and provide passcode 66914033. A live audio webcast of the call also will be available on the homepage of the Company’s website at

A replay of the telephone conference call and audio webcast will be available from approximately 6:00 p.m. ET on April 2, 2013 through midnight on April 16, 2013. To access a replay of the conference call, dial 1-888-286-8010 (U.S. callers) or 1-617-801-6888 (international callers), and provide passcode 22922112.

About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in the field of diagnostic imaging provides a strong platform from which to bring forward breakthrough new tools for the diagnosis and management of disease. Lantheus imaging products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, TechneLite® (Technetium Tc99m Generator), Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection). Lantheus has approximately 600 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia. For more information, visit